ReviewBMJ global health2025
Global insights can accelerate India's journey towards the elimination of lymphatic filariasis as a public health problem.
Review in BMJ global health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Article
- Exploring the landscape of lymphatic filariasis research in India: A scientometric analysis of two decades from 2000 to 2024.PLoS neglected tropical diseases · 2026Article
- Acute Brugian filariasis in a German tourist after short-term travel to Sri Lanka, 2025.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
India has set an ambitious target to achieve the elimination of lymphatic filariasis (LF) as a public health problem by 2027, 3 years ahead of the global target. Achieving this goal demands accelerated progress and evidence-based strategies. This review synthesises insights from the policies and interventions of 21 countries that achieved LF elimination in the past decade (2015-2024). Key lessons for India include integrated disease management, tailored drug distribution, capacity building, targeted outreach to migrant and never-treated populations and enhanced morbidity management strategies. It also highlights the role of robust social mobilisation, vector control strategies and strategic deployment of digital technologies. Tailoring these global practices to India's diverse contexts can address the existing challenges and strengthen last-mile elimination efforts. Moreover, these insights provide a valuable blueprint for other endemic nations striving to achieve similar goals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.